CVE-2026-19532

Summary

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in HAVELSAN Inc. Liman MYS allows Path Traversal.

This issue affects Liman MYS: from 2.3.2 before 2.3.4-1124.

Affected Software

VendorProductVersion RangeStatus
HAVELSAN Inc.Liman MYS2.3.2 < 2.3.4-1124affected

Weaknesses

  • CWE-22: CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

ADP Enrichment

CISA ADP Vulnrichment

  • SSVC:
  • Exploitation: none
    • Automatable: yes
    • Technical Impact: partial

References